AI-generated summary
The authors report on 19 patients with dry eye from meibomian gland dysfunction who received three intense pulsed light sessions. Noninvasive break-up time and lipid layer thickness improved, and 17 of 19 patients reported less ocular discomfort. Meibomian gland loss and tear osmolarity did not change significantly, and the authors note that repeated treatments are usually needed to maintain the benefits.
- Participants
- 19
- Who or what was studied
- 19 patients with dry eye disease caused by meibomian gland dysfunction
- Wavelengths
- 515, 1200 nm
- Limits stated in the abstract
- The abstract describes a small single-group study of 19 patients without a stated control group, and the authors note that repeated treatments are usually needed for lasting effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on app.jove.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 515-1200 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Wavelength, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.